3 Factor Indexing’s Edwards Lifesciences EW Stock Holding History

3 Factor Indexing’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$181	Hold	2	–	–	﹤0.01%	303
2026 Q1	$161	Buy	+2	New	+$165	﹤0.01%	326

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

3 Factor Indexing's EW Position: Q2 2026 in Review

3 Factor Indexing held its Edwards Lifesciences (EW) position steady in Q2 2026 at 2 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #303.

3 Factor Indexing first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.

3 Factor Indexing held 2 shares of Edwards Lifesciences worth $181 as of Q2 2026.
3 Factor Indexing left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #303 holding.
3 Factor Indexing first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.